Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.
Journal: The Journal of urology
Published: May 05, 2024
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial.
Journal: European urology
Published: June 09, 2021
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Journal: The Lancet. Oncology
Published: July 05, 2020
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 12, 2014
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 08, 2012
Robotic versus open radical cystectomy: identification of patients who benefit from the robotic approach.
Journal: Journal of endourology
Published: July 14, 2012
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: February 02, 2012
Health policy: lost in transition, losing money, but caution precludes a "quick fix".
Journal: Nature reviews. Urology
Published: December 14, 2011
Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients.
Journal: Journal of laparoendoscopic & advanced surgical techniques. Part A
Published: December 07, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026